Pharmacist Enhanced Service for Cardiovascular Risk Reduction

NCT04220788 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-09-02

No results posted yet for this study

Summary

Pharmacist services such as medication review, counselling and treatment adherence clinics can improve clinical, health related quality of life and economic outcomes. To prove this hypothesis a step-wedge, cluster randomized controlled trial will be held in primary care centers of the public health system of Malaysia. Participants who have a high risk of cardiovascular risk factors currently seeking care in primary care will be recruited. Control group will receive usual care and the intervention arm will be seen by a pharmacist prior to their follow-up, with a comprehensive medication review, counselling and dietary advice consultations every month for three months. Participating pharmacist will be trained in cardiovascular prevention pharmacotherapy, interview skills, educational techniques, and develop personalized plan for every participant. The investigators plan to randomize up to 2100 participants who are currently receiving care in the primary care clinics in the district of Petaling by modifying the current workflow in primary care, whereby the investigators aim to get participants who are at high risk to undergo counselling as well as a medication review with proper pharmaceutical care delivered to them prior to seeking their medical doctor to receive care.

Conditions

  • Cardiovascular Risk Factor

Interventions

OTHER

Enhanced pharmacist service

Calculation of cardiovascular risk by an online tool for discussion on the CVD risk. Pharmacist will also provide ducation on cardiovascular risk factors and healthy lifestyle. Any prescription adaptation(s), and/or recommendations where necessary to meet lipid, blood pressure and glycemic control targets and smoking cessation will be initiated

OTHER

Usual care

Participants in the arm will receive their care from their respective nurse, doctor or pharmacists as per usual clinic practice

Sponsors & Collaborators

  • Klinik Kesihatan Puchong

    collaborator UNKNOWN
  • Klinik Kesihatan Kelana Jaya

    collaborator UNKNOWN
  • Klinik Kesihatan Shah Alam Seksyen 7

    collaborator UNKNOWN
  • Klinik Kesihatan Shah Alam Seksyen 9

    collaborator UNKNOWN
  • Klinik Kesihatan Taman Medan

    collaborator UNKNOWN
  • Klinik Kesihatan Seri Kembangan

    collaborator UNKNOWN
  • Monash University

    lead OTHER

Principal Investigators

  • Shaun Lee · Monash University Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04220788 on ClinicalTrials.gov